Abstract

BackgroundMost of studies on the relationship between drug use and HIV have focused largely on people who inject drugs. Non-injecting drug use is much more common than injecting drug use, and although it can also predispose people to HIV infection, it is not widely explored. We therefore conducted this study to explore the prevalence of HIV and identify risk factors for HIV infection among people who use non-injecting drugs (PWUD) in Cambodia.MethodsThis cross-sectional study was conducted in 2017. The Respondent Driven Sampling method was used to recruit the study participants who were interviewed face-to-face using a structured questionnaire. Blood samples were collected for HIV and syphilis testing. A multivariable logistic regression analysis was conducted to identify risk factors associated with HIV infection.ResultsIn total, 1367 PWUD were included in this study, whose mean age was 28.0 (SD = 7.7) years. The majority (95.1%) of the participants used methamphetamine. The prevalence of HIV was 5.7, and 35.2% of the identified HIV-positive PWUD were not aware of their status prior to the survey. After adjustment for other covariates, HIV infection remained significantly associated with being in the age group of ≥35 (AOR = 2.34, 95% CI = 1.04–6.11), having lower level of formal education of ≤ 6 years (AOR = 2.26, 95% CI = 1.04–5.15), living on the streets (AOR = 2.82, 95% CI = 1.10–7.23), perception that their HIV risk was higher as compared to that of the general population (AOR = 3.18, 95% CI = 1.27–8.62), having used injecting drugs in lifetime (AOR = 3.8, 95% CI = 1.36–4.56), and having cuts or sores around the genital area in the past 12 months (AOR = 3.42, 95% CI = 1.09–6.33).ConclusionsThe prevalence of HIV among PWUD in this study was more than 10 times higher than the prevalence in the general adult population. The findings reveal a higher vulnerability to HIV infection among specific sub-populations of PWUD, such as those who are homeless, who may benefit from tailored interventions that respond to their specific needs. To enhance HIV case finding, stratification of PWUD to facilitate HIV risk profiling based on socio-economic profiles and drug injection history is recommended.

Highlights

  • Most of studies on the relationship between drug use and human immunodeficiency virus (HIV) have focused largely on people who inject drugs

  • We discussed the potential implications of these findings on HIV prevention policies and programs. Sites, and participants This cross-sectional IBBS 2017 among people who use non-injecting drugs (PWUD) and people who inject drugs (PWID) in Cambodia was conducted from June to December 2017 in the capital city of Phnom Penh and 11 other major provinces purposively selected by the research team and approved by the National Center for HIV/AIDS, Dermatology and STD (NCHADS) and National Authority for Combating Drugs (NACD)

  • This paper presents crucial data regarding the prevalence of HIV and its risk factors among Cambodian PWUD sampled in the most recent national IBBS conducted in 2017

Read more

Summary

Introduction

Most of studies on the relationship between drug use and HIV have focused largely on people who inject drugs. Evidence from a recent systematic review suggested that illicit drug dependence directly accounted for 20 million disability-adjusted life years (DALYs) in 2010, representing 0.8% of global allcause DALYs [2]. This burden of disease is exacerbated by the intersection between the use of illicit drugs, poor mental health, and suicides [2, 3]. The current Cambodia 3.0 framework aims to eliminate new HIV infections in the country by 2020, by accelerating prevention among all key populations including PWUD and PWID, female entertainment workers, men who have sex with men, and transgender women [4]. A key emphasis in the national response is an aspiration to strengthen the availability of data and strategic information related to the HIV epidemic among the key populations [5]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call